Impact of anemia on hospitalization and mortality in older adults

Bruce F Culleton1, Braden J Manns, Jianguo Zhang

  • 1Department of Medicine, University of Calgary, Foothills Hospital, Rm C210, 1403-29th St NW, Calgary, AB, Canada T2N 2T9. bruce.culleton@calgaryhealthregion.ca

Blood
|January 13, 2006
PubMed

Insights

Anemia in older adults significantly increases hospitalization and death risks. Optimal hemoglobin levels for lower mortality differ between men and women, suggesting a need to redefine "normal" values.

Area of Science:

  • Gerontology
  • Hematology
  • Epidemiology

Background:

  • Anemia is prevalent in older adults, but its prognostic implications remain unclear.
  • Understanding anemia's impact on mortality and hospitalization is crucial for geriatric care.

Purpose of the Study:

  • To investigate the association between anemia and outcomes in community-dwelling older adults.
  • To determine the relationship between hemoglobin levels and mortality and hospitalization risks.

Main Methods:

  • A cohort of 17,030 community-dwelling adults aged 66+ was followed for 3 years.
  • Cox proportional hazards models analyzed anemia (hemoglobin < 110 g/L) and hemoglobin levels against mortality and hospitalization.

Main Results:

  • Anemia was linked to significantly higher risks of death (HR 4.29), all-cause hospitalization (HR 2.16), and cardiovascular hospitalization (HR 2.49).
  • An inverse J-shaped curve showed lowest mortality risk at hemoglobin 130-150 g/L for women and 140-170 g/L for men.

Conclusions:

  • Anemia is a significant risk factor for adverse outcomes in older adults.
  • Current "normal" hemoglobin ranges may need reevaluation for the elderly population.
  • Further research, including clinical trials, is needed to assess the benefits of anemia correction.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Factors Affecting Respiration01:24

Factors Affecting Respiration

Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process: